These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2718057)

  • 1. [Personal experience with isolated regional hyperthermic perfusion of cytostatic agents in tumors of the extremities].
    Bríza J; Lichtenberg J; Tersíp K; Tosovský J
    Rozhl Chir; 1989 Feb; 68(2):113-6. PubMed ID: 2718057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regional hyperthermic perfusion--therapeutic concept and long term results].
    Göhl J; Hohenberger W
    Langenbecks Arch Chir Suppl Kongressbd; 1992; ():494-501. PubMed ID: 1493314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of tissue oxygen partial pressure during isolated, hyperthermic limb perfusion with cytostatic drugs or recombinant human tumor necrosis factor alpha combined with melphalan.
    Hohenberger P; Bida B; Schlag PM
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():14-5. PubMed ID: 8946039
    [No Abstract]   [Full Text] [Related]  

  • 4. [Regional chemotherapy--perfusion of the extremities].
    Meyer T; Göhl J
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities.
    Papa MZ; Klein E; Karni T; Koller M; Davidson B; Azizi E; Ben-Ari G
    Am J Surg; 1996 Apr; 171(4):416-20. PubMed ID: 8604833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the method of hyperthermic chemotherapy by regional isolated perfusion for tumors of lower extremities].
    Xu SW; Chen F; Chao YH
    Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):310-3. PubMed ID: 7805565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regional hyperthermic perfusion has impressive effect on manifest malignant melanoma].
    Hafström L
    Lakartidningen; 1992 Sep; 89(39):3189-90. PubMed ID: 1405932
    [No Abstract]   [Full Text] [Related]  

  • 8. [Soft tissue sarcoma: isolated hyperthermic extremity perfusion. Technique and indications].
    Schlag PM; Kettelhack C
    Chirurg; 1993 Jun; 64(6):455-60. PubMed ID: 8359057
    [No Abstract]   [Full Text] [Related]  

  • 9. [Edema caused by isolated hyperthermic perfusion of the extremities].
    Walther H
    Z Lymphol; 1990 Aug; 14(1):24-6. PubMed ID: 2238800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha levels in patients with malignant tumors after hyperthermic isolated regional perfusion.
    Aksaz E; Erdem E; Erdem D; Unal AM
    J Exp Clin Cancer Res; 2002 Dec; 21(4):489-93. PubMed ID: 12636094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities].
    Li J; Wang P; Zhu XJ; Song JG; Song JM
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):937-9. PubMed ID: 23336382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolated hyperthermic extremity perfusion in soft tissue sarcoma].
    Eigler FW; Krause U
    Chirurg; 1997 Jun; 68(6):649. PubMed ID: 9324449
    [No Abstract]   [Full Text] [Related]  

  • 13. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolated hyperthermic perfusion of the extremities with cytostatic agents. A method of treatment in malignant melanoma and soft tissue sarcoma].
    Kettelhack C; Schlag P
    Dtsch Krankenpflegez; 1989 Sep; 42(9):597-601. PubMed ID: 2518209
    [No Abstract]   [Full Text] [Related]  

  • 15. [Regional hyperthermic cytostatic perfusion as an alternative in the treatment of malignant soft tissue tumors of the extremities].
    Ghussen F; Nagel K
    Chirurg; 1984 Aug; 55(8):505-7. PubMed ID: 6488995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytostatic hyperthermic isolated limb perfusion (HILP) in VFN (General Faculty Hospital in Prague)].
    Spacek M; Mitás P; Lacina L; Krajsová I; Hodková G; Salmay M; Spunda R; Brlicová L; Lindner J
    Rozhl Chir; 2011 Jan; 90(1):62-6. PubMed ID: 21634138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New modifications in isolated extremity perfusion ].
    Aigner K; Hild P; Hundeiker M
    Z Hautkr; 1982 Jul; 57(14):1044-54. PubMed ID: 6889794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prognosis of patients with level V melanomas of the extremities].
    Krüger I; Ghussen F; Groth W
    Z Hautkr; 1989 Jul; 64(7):573-6. PubMed ID: 2773539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience in the management of malignant tumors of the limbs using regional perfusion with cytostatics].
    Tomsů M
    Cas Lek Cesk; 1967 Jun; 106(24):652-5. PubMed ID: 5588238
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective randomized study of regional extremity perfusion in patients with malignant melanoma.
    Ghussen F; Nagel K; Groth W; Müller JM; Stützer H
    Ann Surg; 1984 Dec; 200(6):764-8. PubMed ID: 6508407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.